London Health Sciences Centre
🇨🇦Canada
- Country
- 🇨🇦Canada
- Ownership
- Private
- Established
- 1875-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.lhsc.on.ca
Study of Sirolimus Versus Mycophenolate Liver Transplant Recipients With Recurrent Hepatitis C Virus (HCV)
- First Posted Date
- 2010-06-02
- Last Posted Date
- 2015-02-26
- Lead Sponsor
- London Health Sciences Centre
- Target Recruit Count
- 11
- Registration Number
- NCT01134952
- Locations
- 🇨🇦
London Health Sciences Centre, London, Ontario, Canada
The Effect of Erythropietin on Microcircualtory Alteration in Intensive Care Unit Patients With Severe Sepsis
Terminated
- Conditions
- SepsisShock
- First Posted Date
- 2010-03-16
- Last Posted Date
- 2018-03-13
- Lead Sponsor
- London Health Sciences Centre
- Target Recruit Count
- 22
- Registration Number
- NCT01087450
- Locations
- 🇨🇦
London Health Sciences Center-Critical Care Trauma Center, London, Ontario, Canada
Starch or Saline After Cardiac Surgery
Not Applicable
Terminated
- Conditions
- Coronary Artery Bypass Surgery
- Interventions
- Drug: 0.9% Normal SalineDrug: 6% Hydroxyethyl Starch 130/0.4
- First Posted Date
- 2009-08-24
- Last Posted Date
- 2019-08-15
- Lead Sponsor
- London Health Sciences Centre
- Target Recruit Count
- 69
- Registration Number
- NCT00964015
- Locations
- 🇨🇦
London Health Sciences Centre, London, Ontario, Canada
Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma
Phase 1
Completed
- Conditions
- Endometrial CancerUnspecified Adult Solid Tumor, Protocol SpecificKidney CancerLung CancerBreast CancerLymphoma
- First Posted Date
- 2008-04-16
- Last Posted Date
- 2013-05-30
- Lead Sponsor
- London Health Sciences Centre
- Target Recruit Count
- 28
- Registration Number
- NCT00659568
- Locations
- 🇨🇦
London Regional Cancer Program at London Health Sciences Centre, London, Ontario, Canada
Proparacaine vs Placebo for Corneal Injuries
Phase 1
Completed
- Conditions
- Corneal Abrasions
- Interventions
- Drug: saline drops
- First Posted Date
- 2008-02-22
- Last Posted Date
- 2008-02-22
- Lead Sponsor
- London Health Sciences Centre
- Target Recruit Count
- 43
- Registration Number
- NCT00620997
- Locations
- 🇨🇦
London Health Sciences Center, London, Ontario, Canada
Trial Comparing the Safety of Two Different Intravenous Iron Formulations
Phase 4
Suspended
- Conditions
- Iron Deficiency AnemiaPerioperative Blood Conservation
- Interventions
- First Posted Date
- 2008-01-15
- Last Posted Date
- 2009-03-03
- Lead Sponsor
- London Health Sciences Centre
- Target Recruit Count
- 200
- Registration Number
- NCT00593619
- Locations
- 🇨🇦
London Health Sciences Centre, London, Ontario, Canada
Impact of Left Atrial Appendage Exclusion on Short-Term Clinical Outcomes and Long-Term Stroke Incidence
Not Applicable
Completed
- Conditions
- ThromboembolismAtrial FibrillationCerebrovascular Accident
- Interventions
- Procedure: Left Atrial Appendage Ligation
- First Posted Date
- 2007-06-15
- Last Posted Date
- 2019-08-15
- Lead Sponsor
- London Health Sciences Centre
- Target Recruit Count
- 43
- Registration Number
- NCT00486915
- Locations
- 🇮🇹
Hospital San Rafael, Milan, MI, Italy
Trial of Education and Compliance in Heart Dysfunction (TEACH)
Phase 3
Completed
- Conditions
- Heart Failure
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- London Health Sciences Centre
- Target Recruit Count
- 383
- Registration Number
- NCT00211289
- Locations
- 🇨🇦
London Health Sciences Centre, London, Ontario, Canada
🇨🇦Hotel Dieu Grace Hospital, Windsor, Ontario, Canada
Trial of Plasma Exchange for Acute Renal Failure at the Onset of Myeloma
Not Applicable
Completed
- Conditions
- Multiple MyelomaAcute Renal Failure
- First Posted Date
- 2005-07-15
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- London Health Sciences Centre
- Target Recruit Count
- 92
- Registration Number
- NCT00120263
- Locations
- 🇨🇦
Dr W F Clark, London, Ontario, Canada
© Copyright 2025. All Rights Reserved by MedPath